Compare EVGN & RENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVGN | RENX |
|---|---|---|
| Founded | 1999 | 2021 |
| Country | Israel | United States |
| Employees | N/A | 6 |
| Industry | Agricultural Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 7.3M |
| IPO Year | 2013 | N/A |
| Metric | EVGN | RENX |
|---|---|---|
| Price | $0.84 | $1.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | 149.8K | ★ 8.0M |
| Earning Date | 03-05-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $73.33 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $0.09 |
| 52 Week High | $2.42 | $2.03 |
| Indicator | EVGN | RENX |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 82.42 |
| Support Level | $0.81 | $0.13 |
| Resistance Level | $1.23 | N/A |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | 0.01 | 0.15 |
| Stochastic Oscillator | 33.29 | 75.99 |
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
RenX Enterprises Corp is a real estate development and environmental solutions company. It is focused on the direct acquisition and indirect investment in properties across the United States that are intended for development into green single-family or multifamily housing projects. The company also focuses on the monetization of its real estate assets. It processes source-separated green waste and is expanding into the production of sustainable, high-margin potting media and soil substrates through advanced milling technology.